Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

Forbes contributors publish independent expert analyses and insights. I write about health and U.K. health policy. Although it's often thought of as a disease of the past, tuberculosis is still found ...

For some forms of tuberculosis, the chances that an exposed person will get infected depend on whether the individual and the bacteria share a hometown, according to a new study comparing how ...

Here's what tuberculosis is, how it's transmitted and how you can expect to have it treated if it affects you or someone you ...

A recent Npj Vaccines study discussed the success and challenges of developing different tuberculosis (TB) vaccine types. Study: Key advances in vaccine development for tuberculosis—success and ...

TB is an airborne disease with a long history, now primarily treated with antibiotics, but drug resistance remains a challenge. The COVID-19 pandemic led to underdiagnosis and increased TB mortality, ...

Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, affecting millions annually despite being preventable and curable. Understanding how TB spreads is crucial for both ...

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not ...